Reza Shojaei: Transforming Canada’s Plasma System for Greater Resilience and Self-Sufficiency
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared a post on Linkedln:
”Canada’s plasma system is quietly undergoing one of its most important transformations in decades.
Rising demand for immunoglobulins, growing pressure on global supply chains, and years of heavy reliance on imported plasma-derived medicines have pushed plasma fractionation from a technical topic into a strategic health policy priority.
Three forces converging in 2025 were:
- accelerated growth in plasma-derived medicinal products (especially immunoglobulins).
- deliberate expansion of domestic plasma collection.
- regulatory and formulary modernization reshaping how these products are assessed, manufactured, and supplied.
This is not just a market story; it’s a resilience story.
In the latest issue of Blood and Plasma Pulse, we examine:
- where Canada’s plasma fractionation market truly stands today
- how public–private partnerships are re-engineering the supply chain
- why regulatory changes in 2025 matter far beyond compliance
- what still stands between policy ambition and domestic self-sufficiency
For healthcare leaders, regulators, biotech professionals, and anyone thinking about system sustainability, this transition will shape availability, access, and risk for years to come.”
Find more posts featuring Reza Shojae on Hemostasis Today.
-
Feb 11, 2026, 17:00A Major Step Forward for the Global Bleeding Disorders Community – Haemophilia Foundation Australia
-
Feb 11, 2026, 16:47Pall T. Onundarson and Mandeep Mehra on Diverse Approaches to Anticoagulation in LVAD Patients
-
Feb 11, 2026, 16:37Rahul Gosain: Are Cancer Outcomes Directly Related to Lymphocyte Counts?
-
Feb 11, 2026, 16:35Are DOACs Actually Safer in Advanced Cirrhosis – RPTH Journal
-
Feb 11, 2026, 16:31Pat Garcia-Gonzalez: A Bold Plan to Double Impact and Reach 100,000 Patients by 2031
-
Feb 11, 2026, 16:20Ney Carter Borges։ Clinical Importance of Coronary Microcirculation in MINOCA and INOCA
-
Feb 11, 2026, 16:18The Hidden Risks of Blood Thinners and the Need for Safer Anticoagulants – National Blood Clot Alliance
-
Feb 11, 2026, 16:13Thomas Reiser: A Great Opportunity to Advance the Field of Thrombosis and Hemostasis
-
Feb 11, 2026, 16:12Annabel Hölzle Takes Runner-Up Award in Basic Science and Translational Research at ESC Heart and Stroke 2025